Mammogram Screening for Women Aged 40-41
Author Information
Author(s): Sue Moss, I Thomas, A Evans, B Thomas, L Johns
Primary Institution: Cancer Screening Evaluation Unit, Institute of Cancer Research
Hypothesis
Does annual mammographic screening from age 40 reduce breast cancer mortality compared to screening starting at age 50?
Conclusion
The trial suggests that annual mammographic screening starting at age 40 may have benefits, but the effectiveness remains uncertain.
Supporting Evidence
- 160,921 women were randomized in the trial.
- Uptake of screening invitations was between 68% and 70%.
- Invasive cancer detection rates were 0.09% at the first screen.
- Mortality analysis will be conducted once data ascertainment is complete.
Takeaway
This study looked at whether women aged 40 could benefit from regular mammograms. It found that while many women got screened, it's still unclear if it really helps them live longer.
Methodology
The study randomized 160,921 women aged 40-41 to receive annual mammograms or no intervention, tracking outcomes over 10 years.
Potential Biases
Potential contamination from private screening in the control group could bias results.
Limitations
Some centers ceased screening early due to resource constraints, which may affect the results.
Participant Demographics
Women aged 40-41, with a total of 160,921 participants randomized.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI 0.63, 1.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website